Efficacy and safety of tipepidine as adjunctive therapy in children with attention‐deficit/hyperactivity disorder: Randomized, double‐blind, placebo‐controlled clinical trial

Attention Deficit ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial

Advances in Integrative Medicine ◽

10.1016/j.aimed.2022.01.002 ◽

2022 ◽

Author(s):

Benyamin Pazoki ◽

Nadia Zandi ◽

Zeinab Assaf ◽

Hossein Sanjari Moghaddam ◽

Arefeh Zeinoddini ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

l-Carnosine as Adjunctive Therapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2017.0157 ◽

2018 ◽

Vol 28 (5) ◽

pp. 331-338 ◽

Cited By ~ 7

Author(s):

Alireza Ghajar ◽

Farinaz Aghajan-Nashtaei ◽

Mohsen Afarideh ◽

Mohammad-Reza Mohammadi ◽

Shahin Akhondzadeh

Keyword(s):

Clinical Trial ◽

Children And Adolescents ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Double Blind ◽

Double Blind Placebo ◽

Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial

The International Journal of Neuropsychopharmacology ◽

10.1093/ijnp/pyv094 ◽

2015 ◽

Vol 19 (3) ◽

pp. pyv094 ◽

Cited By ~ 17

Author(s):

Hsiang-Yuan Lin ◽

Susan Shur-Fen Gau

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Double Blind ◽

Double Blind Placebo ◽

Functional Brain ◽

Hyperactivity Disorder ◽

Functional Brain Networks ◽

Atomoxetine Treatment

A randomised, double-blind, placebo-controlled clinical trial of a Compound Herbal Preparation (CHP) in the treatment of children with Attention-Deficit Hyperactivity Disorder (ADHD)

http://isrctn.org/> ◽

10.1186/isrctn10628149 ◽

2012 ◽

Author(s):

Aliza Adar Levine

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Herbal Preparation ◽

Double Blind ◽

Double Blind Placebo ◽

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on Once-Daily Atomoxetine Hydrochloride in Taiwanese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2006.0091 ◽

2007 ◽

Vol 17 (4) ◽

pp. 447-460 ◽

Cited By ~ 42

Author(s):

Susan S.F. Gau ◽

Yu-Shu Huang ◽

Wei-Tsuen Soong ◽

Miao-Chun Chou ◽

Wen-Jiun Chou ◽

...

Keyword(s):

Clinical Trial ◽

Children And Adolescents ◽

Attention Deficit ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

The effect of phosphatidylserine administration on memory and symptoms of attention‐deficit hyperactivity disorder: a randomised, double‐blind, placebo‐controlled clinical trial

Journal of Human Nutrition and Dietetics ◽

10.1111/jhn.12090 ◽

2013 ◽

Vol 27 (s2) ◽

pp. 284-291 ◽

Cited By ~ 24

Author(s):

S. Hirayama ◽

K. Terasawa ◽

R. Rabeler ◽

T. Hirayama ◽

T. Inoue ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

The World Journal of Biological Psychiatry ◽

10.3109/15622975.2011.600333 ◽

2011 ◽

Vol 14 (4) ◽

pp. 268-281 ◽

Cited By ~ 9

Author(s):

Miguel Casas ◽

Michael Rösler ◽

J. J. Sandra Kooij ◽

Ylva Ginsberg ◽

Josep Antoni Ramos-Quiroga ◽

...

Keyword(s):

Attention Deficit ◽

Fixed Dose ◽

Prolonged Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Dose Study

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

Behavioral and Brain Functions ◽

10.1186/1744-9081-6-34 ◽

2010 ◽

Vol 6 (1) ◽

pp. 34 ◽

Cited By ~ 86

Author(s):

Timothy Wigal ◽

Matthew Brams ◽

Maria Gasior ◽

Joseph Gao ◽

Liza Squires ◽

...

Keyword(s):

Crossover Study ◽

Attention Deficit ◽

Environment Design ◽

Efficacy And Safety ◽

Lisdexamfetamine Dimesylate ◽

Double Blind ◽

Workplace Environment ◽

Double Blind Placebo ◽

Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: A 4-week, randomized, double-blind, placebo-controlled, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2006.02.011 ◽

2006 ◽

Vol 28 (2) ◽

pp. 266-279 ◽

Cited By ~ 64

Author(s):

Thomas J. Spencer ◽

Timothy E. Wilens ◽

Joseph Biederman ◽

Richard H. Weisler ◽

Stephanie C. Read ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Parallel Group Study ◽

Parallel Group ◽

Adolescent Patients

A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Clinical Trial of ORADUR-Methylphenidate for Treating Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2020.0104 ◽

2020 ◽

Author(s):

Yu-Shu Huang ◽

Chin-Bin Yeh ◽

Chin-Hung Chen ◽

Chi-Yung Shang ◽

Susan Shur-Fen Gau

Keyword(s):

Clinical Trial ◽

Children And Adolescents ◽

Attention Deficit ◽

Double Blind ◽

Double Blind Placebo ◽